Investor Relations Update As of November 4, 2025 Safe Harbor Statement Except for historical information contained herein, the matters set forth in this presentation contain forward-looking statements, including industry market projections; our revenue growth opportunities; our ability to fuel product and application diversification; our ability to maintain our leadership position in smartphone audio; our ability to increase HPMS content in smartphones; our ability to leverage our strength in audio and HPMS ...

业绩总结 - 2025年第三季度收入为8200万美元，同比增长34%[10] - 2025年第三季度毛利润为6500万美元，毛利率为79%[10] - 2025年第三季度调整后EBITDA为400万美元，调整后EBITDA率为5%[10] - 2025年第三季度末现金及现金等价物为5600万美元，债务为1900万美元[10] - 公司2024财年第一季度总收入为6450万美元，同比增长3.7%[85] - 公司2024财年第一季度总毛利为5170万美元，毛利率为80.1%[85] - 公司2024财年第一季度非GAAP调整后EBITDA为190万美元，EBITDA利润率为2.9%[86] - 公司2024财年第一季度总现金及等价物为6790万美元[85] 用户数据 - 2025年第三季度活跃买家数量为160万，同比增长26%[10] - 2025年第三季度订单数量为160万，同比增长37%[10] - 2024财年第一季度TTM活跃买家数量为129.6万，同比增长-2.5%[85] - 2024财年第一季度订单总数为118.2万，同比增长7.4%[85] 市场展望 - 预计2024-2029年美国二手服装市场年均增长率为9%[44] - 2024年美国二手服装市场增长14%，是整体零售服装市场的5倍[46] 新产品与技术 - 2024年通过RaaS项目列出230万件商品[55] - 2024年买家节省的金额达到76亿美元，相当于估计零售价格的90%[55] 费用与损失 - 2023年12月31日的持续经营损失为84,720万美元，2024年3月31日的持续经营损失为121,900万美元[89] - 2023年12月31日的调整后EBITDA为25,420万美元，2024年3月31日的调整后EBITDA为18,880万美元，调整后EBITDA利润率分别为4.1%和2.2%[89] - 2023年12月31日的股票补偿费用为65,070万美元，2024年3月31日的股票补偿费用为69,110万美元[89] - 2023年12月31日的折旧和摊销费用为36,650万美元，2024年3月31日的折旧和摊销费用为37,480万美元[89] - 2023年12月31日的利息费用为7,090万美元，2024年3月31日的利息费用为6,770万美元[89] - 2023年12月31日的裁员及其他重组费用为138万美元，2024年3月31日的裁员及其他重组费用为2,731万美元[89] - 2023年12月31日的销售、一般和行政费用为42,460万美元，2024年3月31日的销售、一般和行政费用为36,630万美元[89] - 2024财年第一季度总运营费用为6410万美元，同比仅增长1.3%[86] - 2024财年第一季度市场营销费用同比下降18.9%[86] - 2024财年第一季度销售、一般和行政费用占收入的25.0%[86] - 2024财年第一季度运营、产品和技术费用占收入的57.5%[86]

3Q 2025 Earnings Conference Call November 4, 2025 Forward-Looking Statements Statements made during this presentation that set forth expectations, predictions, projections or are about future events are based on facts and situations that are known to us as of November 4, 2025. We believe that our expectations and assumptions are reasonable. Actual results may differ materially, due to risks and uncertainties, such as those described on pages 24-35 of our Form 10-Q filed on May 6, 2025 and other subsequent f ...

Stoke Therapeutics Third Quarter 2025 Business Update Webcast for Investors & Analysts November 4, 2025 © COPYRIGHT 2025 | STOKE THERAPEUTICS | 1 Forward-Looking Statements and Other Legal Notices This presentation has been prepared by Stoke Therapeutics, Inc. ("Stoke" or "us") for informational purposes only and not for any other purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by the presenter(s) or Stoke or any officer, director, e ...

Company Overview November 4, 2025 1 Disclaimers This presentation contains forward-looking statements. All statements contained in this presentation other than statements of historical facts, including, without limitation, statements regarding our market opportunity, demand for our product and service offerings, expectations regarding our annualized recurring revenue (ARR), free cash flow, and our other non-GAAP measures, our business strategy, plans and objectives for future operations and expectations reg ...

November 2025 Q3'25 Earnings Results Teradata Investor Relations Forward-looking statements This release contains forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934. Forward-looking statements generally relate to opinions, beliefs, and projections of expected future financial and operating performance, business trends, liquidity, and market conditions, among other things. These forward-looking statements are based upon current expectations and assumptions ...

3Q Earnings Presentation November 2025 Copyright © 2025 agilon health. Confidential internal document containing proprietary information. Do not distribute. Disclaimers and Forward-Looking Statements FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION Statements in this presentation that are not historical factual statements are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-lo ...

In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this presentation, and although we believe such information forms a reasonable basis for su ch statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant informatio ...

Investor Presentation. November 2025 Disclaimer. Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All state ...

Q3 2025 Financial Results & Commentary November 4, 2025 Cautionary Statements & Disclosures This presentation and the accompanying oral presentation contain "forward-looking" statements that are based on our management's beliefs and assumptions, including statements regarding our strategy, market, operations, profitability and positioning. Q3'25: Broad-Based Improvements Revenue Overview Consistent Profitability Forward-looking statements are subject to known and unknown risks and uncertainties and are base ...